Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

Rentschler Announces 3rd Industrial Cell Culture Technology Conference

Published: Saturday, March 15, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
“Laupheimer Zelltage” to be held on June 2-3, 2014 in Laupheim, Germany.

Virus-based biologics play an increasing role in the development of innovative gene, immuno and virotherapeutics. Novel virus-based carrier technologies such as virus-like particles are breaking into new vaccine sectors.

The first approval of a gene therapeutic (Glybera®) in Europe as well as various reports of success from gene therapy trials are bolstering confidence in the potential of gene therapy. Also the development of oncolytic viruses for cancer immunotherapy is attracting more and more attention.

Common to all of these virus-based biologics is their high degree of complexity, creating the necessity for high levels of understanding of virus and cell biology as well as a multiplicity of innovative technologies. The manufacturing of virus-based biologics is setting new standards for process development and analytical and regulatory requirements.

Against this background Rentschler invites under the heading Processes for Virus-based Biologics to the third Industrial Cell Culture Technology Conference. The conference will take place on June 2-3, 2014 at Laupheim's historical castle, Schloss Großlaupheim.

With the Industrial Cell Culture Technology Conference “Laupheimer Zelltage” Rentschler has established a unique platform for the international exchange of knowledge, ideas and expertise.

Held every two years, it attracts global leaders and forward thinkers in the field of biotechnology. As these experts discuss the application of cutting-edge developments, important breakthroughs emerge in the manufacturing of biologics.

Processes for Virus-based Biologics include all aspects related to platform technologies for the manufacturing and control of viral biopharmaceuticals including viral vectors, oncolytic viruses and virus-based vaccines.

The conference will bring together international academic and industrial experts in cell culture and process technology for the production of virus-based biologics and is the first conference of its type eagerly awaited by the scientific and industrial community.

The keynote lecture will be held by Florian Wurm (Swiss Federal Institute of Technology). The full program and organization details can be found here:

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rentschler Invests EUR 24 Million in Stainless Steel Bioreactor Manufacturing
The Twin system should be operational in early 2017.
Saturday, June 21, 2014
Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos